- Home
- BLRX vs KXIN Comparison
BLRX vs KXIN Comparison
Compare BLRX & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLRX
- KXIN
- Stock Information
- Founded
- BLRX 2003
- KXIN 2015
- Country
- BLRX Israel
- KXIN China
- Employees
- BLRX N/A
- KXIN N/A
- Industry
- BLRX Biotechnology: Pharmaceutical Preparations
- KXIN Retail-Auto Dealers and Gas Stations
- Sector
- BLRX Health Care
- KXIN Consumer Discretionary
- Exchange
- BLRX Nasdaq
- KXIN Nasdaq
- Market Cap
- BLRX 12.1M
- KXIN 13.0M
- IPO Year
- BLRX 2011
- KXIN N/A
- Fundamental
- Price
- BLRX $5.74
- KXIN $0.96
- Analyst Decision
- BLRX Strong Buy
- KXIN
- Analyst Count
- BLRX 2
- KXIN 0
- Target Price
- BLRX $19.00
- KXIN N/A
- AVG Volume (30 Days)
- BLRX 2.0M
- KXIN 209.5K
- Earning Date
- BLRX 05-27-2025
- KXIN 01-01-0001
- Dividend Yield
- BLRX N/A
- KXIN N/A
- EPS Growth
- BLRX N/A
- KXIN N/A
- EPS
- BLRX N/A
- KXIN N/A
- Revenue
- BLRX $22,340,000.00
- KXIN N/A
- Revenue This Year
- BLRX N/A
- KXIN N/A
- Revenue Next Year
- BLRX N/A
- KXIN N/A
- P/E Ratio
- BLRX N/A
- KXIN N/A
- Revenue Growth
- BLRX 91.68
- KXIN N/A
- 52 Week Low
- BLRX $2.30
- KXIN $0.64
- 52 Week High
- BLRX $35.60
- KXIN $29.54
- Technical
- Relative Strength Index (RSI)
- BLRX 73.10
- KXIN 49.48
- Support Level
- BLRX $3.88
- KXIN $0.91
- Resistance Level
- BLRX $7.77
- KXIN $0.99
- Average True Range (ATR)
- BLRX 0.75
- KXIN 0.07
- MACD
- BLRX 0.19
- KXIN 0.00
- Stochastic Oscillator
- BLRX 56.81
- KXIN 20.00
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About KXIN Kaixin Auto Holdings
Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.